Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | FLT3 | P36888 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20152807 | 0.93 | MAPT (0.35) | MAPTTSHRMAPK1NPSR1HSD17B10 | |
| SCHEMBL20152693 | 0.91 | FLT3 (0.30) | FLT3 | |
| SCHEMBL20152820 | 0.90 | MAPT (0.35) | MAPTTSHRMAPK1NPSR1HSD17B10 | |
| SCHEMBL20152675 | 0.90 | MEN1 (0.32) | MAPTNPSR1HPGDFLT3 | |
| SCHEMBL20152674 | 0.90 | MEN1 (0.32) | MAPTNPSR1HPGDFLT3 | |
| SCHEMBL20152780 | 0.89 | MAPT (0.34) | MAPTTSHRMAPK1NPSR1HSD17B10 | |
| SCHEMBL20152677 | 0.89 | KDM4E (0.31) | MAPTHPGD | |
| SCHEMBL20152663 | 0.88 | DUSP3 (0.31) | MAPTTSHRMAPK1HSD17B10HPGD | |
| SCHEMBL20152589 | 0.88 | MAPT (0.35) | MAPTTSHRMAPK1NPSR1HSD17B10 | |
| SCHEMBL20152668 | 0.87 | MEN1 (0.32) | MAPTTSHRMAPK1NPSR1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10580996-B2 | Polycyclic compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2020-03-03 | — | — | US | disclosed |
| US-20180138421-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
| US-20180138421-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180138421-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY2, NR2E3, CRY1 | MAPT 530/4885TSHR 4377/4885MAPK1 4059/4885 |
| US-10580996-B2 | Polycyclic compound and organic light-emitting element comprising same | CRY2, NR2E3, CRY1 | MAPT 530/4885TSHR 4377/4885MAPK1 4059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.